Literature DB >> 15602101

Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report.

Andrew Wei-Chiang Yeh1, Joseph W Y Lee, Tsun-Chi Cheng, Jung-Kwang Wen, Wei-Hsi Chen.   

Abstract

Catatonia as a clozapine withdrawal syndrome has not been well documented. There is only 1 case of excited catatonia described with the diagnosis made according to strict criteria. The authors report a patient who developed a catatonic stuporous state following abrupt discontinuation of clozapine, associated with features of cholinergic and serotonergic hyperactivity. The catatonic state resolved within 1 week with reinstatement of clozapine. It is suggested that serotonergic hyperactivity was involved, contributed by cholinergic rebound, in the pathogenesis of this patient's clozapine withdrawal catatonic syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602101     DOI: 10.1097/01.wnf.0000145506.99636.1b

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  7 in total

1.  Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.

Authors:  Niko Seppälä; Carita Kovio; Esa Leinonen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Special medical conditions associated with catatonia in the internal medicine setting: hyponatremia-inducing psychosis and subsequent catatonia.

Authors:  Andrei A Novac; Daniela Bota; Joanne Witkowski; Jorge Lipiz; Robert G Bota
Journal:  Perm J       Date:  2014

3.  High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure.

Authors:  Megan K Skelly; Tammie Lee Demler; Claudia Lee
Journal:  Innov Clin Neurosci       Date:  2019-07-01

4.  Catatonia Secondary to Sudden Clozapine Withdrawal: A Case with Three Repeated Episodes and a Literature Review.

Authors:  John Bilbily; Betsy McCollum; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2017-03-15

Review 5.  Review of withdrawal catatonia: what does this reveal about clozapine?

Authors:  Matthew Lander; Tarun Bastiampillai; Jitender Sareen
Journal:  Transl Psychiatry       Date:  2018-07-31       Impact factor: 6.222

6.  A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder.

Authors:  Andrea Galova; Patricia Berney; Jules Desmeules; Ioannis Sergentanis; Marie Besson
Journal:  BMC Psychiatry       Date:  2019-02-19       Impact factor: 3.630

7.  Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?

Authors:  Graham Blackman; Ebenezer Oloyede; Mark Horowitz; Robert Harland; David Taylor; James MacCabe; Philip McGuire
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.